Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 6/20 | 0.46 |
| ▸ | CBFB | Q13951 | 1/20 | 0.36 |
| ▸ | CCR1 | P32246 | 1/20 | 0.35 |
| ▸ | CCR5 | P51681 | 1/20 | 0.35 |
| ▸ | CCR8 | P51685 | 1/20 | 0.35 |
| ▸ | METAP2 | P50579 | 3/20 | 0.35 |
| ▸ | METAP1 | P53582 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15003039 | 1.00 | TERT (0.46) | TERTCBFBCCR1CCR5CCR8 | |
| SCHEMBL4271237 | 1.00 | TERT (0.46) | TERTCBFBCCR1CCR5CCR8 | |
| SCHEMBL14999536 | 1.00 | TERT (0.46) | TERTCBFBCCR1CCR5CCR8 | |
| SCHEMBL23631759 | 0.99 | TERT (0.45) | TERTCBFBCCR1CCR5CCR8 | |
| SCHEMBL23631762 | 0.99 | TERT (0.45) | TERTCBFBCCR1CCR5CCR8 | |
| Hydrochloric Acid SCHEMBL2553046 | 0.89 | TERT (0.52) | TERT | |
| Hydrochloric Acid SCHEMBL2555716 | 0.89 | TERT (0.52) | TERT | |
| SCHEMBL450416 | 0.89 | TERT (0.54) | TERT | |
| SCHEMBL17668308 | 0.88 | TERT (0.53) | TERT | |
| Hydrochloric Acid SCHEMBL2555721 | 0.88 | TERT (0.53) | TERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8633123-B2 | Catalysts and methods for polymer synthesis | NOVOMER, INC. (US) | 2014-01-21 | — | — | US | disclosed |
| US-7485721-B2 | Substituted porphyrins | DUKE UNIVERSITY (US) | 2009-02-03 | — | — | US | disclosed |
| US-20080207582-A1 | Substituted Porphyrins | DUKE UNIVERSITY (US) | 2008-08-28 | — | — | US | disclosed |
| US-20040058902-A1 | Substituted porphyrins | DUKE UNIVERSITY | 2004-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207582-A1 | Substituted Porphyrins | SOD3, MPO, SOD1 | TERT 1398/4885CBFB 2087/4885CCR1 4333/4885 |
| US-20040058902-A1 | Substituted porphyrins | SOD1, SOD3, CAT | TERT 1933/4885CBFB 3269/4885CCR1 2903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.